Directory › Frontage Laboratories

Frontage Laboratories — Exton

Exton, Pennsylvania, United States · Testing lab

This is a record of what regulators published, not a rating.

Site facts

Company
Frontage Laboratories
Name(s) in FDA data
Frontage Laboratories, Inc.
FEI number(s)
3006799640 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Exton, Pennsylvania, United States 19341
Records matched
15 FDA inspections · 2 inspections with posted 483 citations
Most recent FDA inspection in dataset
18 Jun 2026 — VAI

Capabilities (from the company's website)

  • Bioanalytical
    …s,... ... Read More news January 2, 2024 Frontage Laboratories Acquires Accelera S.r.l.’s Bioanalytical and... ... Read More Turning Services into Solutions 25 Years of Successful Growth 28 S…

Taken from the part of the company's network/locations page that describes this site. Source: https://www.frontagelab.com/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 18 Jun 2026
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Bioresearch Monitoring.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1330228)

  2. 14 Apr 2026
    Form 483 observations 4 posted Form 483 citation(s)

    Citation summaries (4)
    • 21 CFR 211.160(b): Scientifically sound laboratory controls
    • 21 CFR 211.192: Written record of investigation incomplete
    • 21 CFR 211.194(a)(4): Data secured in course of each test
    • 21 CFR 211.68(b): Backup file not maintained

    Source: FDA Data Dashboard – Citations (FEI 3006799640, inspection ID 1312304)

  3. 14 Apr 2026
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1312304)

  4. 05 Sep 2025
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Bioresearch Monitoring.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1281730)

  5. 10 Jan 2025
    Form 483 observations 3 posted Form 483 citation(s)

    Citation summaries (3)
    • 21 CFR 211.160(b): Scientifically sound laboratory controls
    • 21 CFR 211.192: Investigations of discrepancies, failures
    • 21 CFR 211.84(d)(2): Reports of Analysis (Components)

    Source: FDA Data Dashboard – Citations (FEI 3006799640, inspection ID 1258228)

  6. 10 Jan 2025
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Veterinary. Project area(s): Pre-Approval Eval. of Animal Drugs and Food Additives.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1258228)

  7. 31 Mar 2023
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Bioresearch Monitoring.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1203309)

  8. 15 Oct 2021
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1155307)

  9. 01 Nov 2019
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1112214)

  10. 20 Apr 2018
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Bioresearch Monitoring.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 1051857)

  11. 18 Mar 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 965450)

  12. 17 Mar 2016
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 965423)

  13. 30 Aug 2013
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 846768)

  14. 17 Jan 2012
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 763276)

  15. 05 Apr 2011
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 727036)

  16. 19 Mar 2010
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 653017)

  17. 07 Apr 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3006799640, inspection ID 578523)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.